“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.
The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.
A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.
Publications found:
253,269
Sort by:
Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major squamous cell carcinoma markets reached a value of US$ 693.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,402.7 Million by 2034, exhibiting a growth rate (C...
May 2024
138 pages
Status Epilepticus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major status epilepticus markets reached a value of US$ 884 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,338.0 Million by 2034, exhibiting a growth rate (CAGR) of...
May 2024
137 pages
Surgical Site Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major surgical site infections markets reached a value of US$ 664.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,174.5 Million by 2034, exhibiting a growth rate (...
May 2024
135 pages
Synucleinopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major synucleinopathies markets reached a value of US$ 661.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,095.2 Million by 2034, exhibiting a growth rate (CAGR) o...
May 2024
131 pages
Systemic Juvenile Idiopathic Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major systemic juvenile idiopathic arthritis markets reached a value of US$ 900 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,250 Million by 2034, exhibiting a gro...
May 2024
135 pages
Tauopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major tauopathies markets reached a value of US$ 661.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,493.0 Million by 2034, exhibiting a growth rate (CAGR) of 7.68...
May 2024
138 pages
Thyroid Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major thyroid cancer markets reached a value of US$ 303.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,624.3 Million by 2034, exhibiting a growth rate (CAGR) of 1...
May 2024
139 pages
Thyroid Eye Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major thyroid eye disease markets reached a value of US$ 2,122.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,139.7 Million by 2034, exhibiting a growth rate (CAG...
May 2024
131 pages
Tourette Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Tourette syndrome markets reached a value of US$ 1,818.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,710.2 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
135 pages
Treatment Resistant Depression Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major treatment resistant depression markets reached a value of US$ 3,295.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6,286.7 Million by 2034, exhibiting a growt...
May 2024
139 pages
Triple-negative Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The triple-negative breast cancer market reached a value of US$ 490.5 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach...
May 2024
129 pages
Type 1 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The type 1 diabetes market reached a value of US$ 5.6 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 9.4 Billion...
May 2024
129 pages
Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The type 2 diabetes market reached a value of US$ 23.4 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 42.8 Billi...
May 2024
140 pages
